Trial NCT02860494

View at ClinicalTrials.gov 
Org. Study IDs: 69HCL16_0062
Secondary IDs: 2018-002531-18

Last trial update was posted on 2021-05-03

MeSH Interventions

Everolimus

MeSH Conditions

Angiofibroma Sclerosis Tuberous Sclerosis

Other Conditions

Facial Angiofibromas

Stopping Reasons

Pharmaceutical and financial difficulties

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID